GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China NT Pharma Group Co Ltd (HKSE:01011) » Definitions » 5-Year Dividend Growth Rate

China NT Pharma Group Co (HKSE:01011) 5-Year Dividend Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is China NT Pharma Group Co 5-Year Dividend Growth Rate?

China NT Pharma Group Co's Dividends per Share for the six months ended in Jun. 2024 was HK$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

China NT Pharma Group Co's Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, China NT Pharma Group Co's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of China NT Pharma Group Co's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, China NT Pharma Group Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China NT Pharma Group Co's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China NT Pharma Group Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where China NT Pharma Group Co's 5-Year Dividend Growth Rate falls into.



China NT Pharma Group Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


China NT Pharma Group Co  (HKSE:01011) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

China NT Pharma Group Co's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ 0.003
=0.00

During the past 13 years, the highest Dividend Payout Ratio of China NT Pharma Group Co was 0.22. The lowest was 0.10. And the median was 0.16.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of China NT Pharma Group Co was 22.70%. The lowest was 0.00%. And the median was 1.51%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China NT Pharma Group Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of China NT Pharma Group Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


China NT Pharma Group Co Business Description

Traded in Other Exchanges
N/A
Address
198 Wellington Street, 28th Floor, The Wellington, Sheung Wan, Hong Kong, HKG
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The company operates in a single segment of Proprietary product production and sales. The company earns the majority of its revenue from the domestic market. The Group's revenue from an external customer was derived solely from its operations in the PRC.
Executives
Ieong Chong Mang
Golden Base Investment Limited
Shum Ning
Chin Yu
Ng Tit
Wang Minzhi 2101 Beneficial owner

China NT Pharma Group Co Headlines

No Headlines